Vertebrate primitive hematopoietic and vascular development is regulated by a conserved set of transcription factors. Their common precursors, the hemangioblasts, express Stem cell leukemia/T-cell acute lymphoblastic leukemia 1 (SCL/TAL1)1 and Lim only protein 2 (LMO2)2 in all vertebrate groups examined. Hemangioblast specification from nascent mesoderm was reported to be less conserved, with Ets variant 2 (ETV2) and Neuronal PASdomain containing protein 4-like (NPAS4L) identified as its master regulator in mammals3 and zebrafish,4 respectively. We show here that the ortholog of NPAS4L, but not of ETV2, is present in the avian genome. Chicken NPAS4L is expressed in hemangioblasts prior to SCL/TAL1 and LMO2. CRISPR-on mediated ectopic expression of endogenous NPAS4L leads to ectopic SCL/TAL1 and LMO2, as with ectopic expression of zebrafish NPAS4L. We propose that the ancestral amniote genome had both NPAS4L and ETV2 genes. The ETV2 gene was lost in the avian lineage without affecting direct transcriptional regulation of SCL/TAL1 and LMO2 by NPAS4L.5,6 The NPAS4L gene was lost in the mammalian lineage, with its roles partially replaced by ETV2.
Vertebrate primitive hematopoietic and vascular systems are derived from the mesoderm germ layer.7,8 Lineage specification events taking place between gastrulation and the onset of circulation are controlled by a set of evolutionarily-conserved transcription regulators.8,9 In birds,10-12 as in fish, amphibians and mammals,13-17 common progenitors of blood and endothelial cells (the hemangioblasts) start to express transcription factors SCL/TAL1 and LMO2 at Hamburger and Hamilton stage 4+ (HH4+),18 soon after their exit from posterior primitive streak where ventral mesoderm cells originate. This is followed by FGFR-mediated segregation of blood and endothelial lineages and functional differentiation of blood cells starting from HH7,10 mediated by a conserved set of transcription factors including SCL/TAL1, LMO2, GATA-binding factor 2 (GATA2), LIM domain-binding protein 1 (LDB1) and transcription factor E2A (E2A).19 After the onset of circulation from HH12/13, the hemangioblast markers SCL/TAL1 and LMO2 become restricted to the blood and endothelial lineages, respectively.
Hemangioblast specification from their mesoderm precursors was reported to involve divergent transcriptional regulation, with ETV2 in mammals3,20 and NPAS4L in zebrafish4 as the main driver. ETV2 ortholog is present in the zebrafish genome, but its function was reported to be under the control of NPAS4L.4,6 No NPAS4L ortholog has been identified in any mammalian species, suggesting that this gene is not involved in hemangioblast specification in mammals. Mammalian NPAS4, a homolog of NPAS4L, was able to rescue fish cloche (npas4l) mutant phenotypes.4 Duplication of the NPAS4 and NPAS4L genes, however, took place before the divergence of Actinopterygians (ray-finned fish, including the teleosts) and Sarcopterygians (lobe-finned fish, including the tetrapods) and NPAS4 has not been associated so far with any aspect of vertebrate hematopoietic development, suggesting that these two genes have different biological functions involving separate molecular regulatory networks.
Since the mammals and birds are closely related both phylogenetically (Figure 1A) and ontogenetically (Figure 1B), we investigated whether avian NPAS4 and ETV2 genes are involved in early hematopoietic and vascular development. Molecular phylogenetic analysis indicated that an NPAS4L ortholog was present in the chicken (G. gallus) genome (in both galGal5 and galGal6 assemblies) (Figure 1C). Although this gene is annotated as NPAS4 in the current assembly, syntenic analysis (Figure 1C) clearly indicated that it was the ortholog of NPAS4L in fish and other vertebrate groups (viewable through search term “npas4” in the NCBI genome data browser https://www.ncbi.nlm.nih.gov/genome/gdv/?org=gallus-gallus or the chicken FANTOM dataset browser http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=b1zZI1gUFZ6mHX6-4Gvxr). Phylogenetic analyses also showed that the NPAS4L gene is present in all other bird species with their genomes fully or partially assembled and in nonavian reptiles with their genomes assembled (Anolis lizard shown as an example in Figure 1C). In contrast, the ETV2 ortholog is missing in the entire avian lineage, and also in crocodiles and turtles, suggesting a loss of this gene before avian evolution. The ETV2 ortholog, however, was found in some of the reptilian lineages (e.g., lizards and snakes) (Figure 1C and D). Taken together, our phylogenetic analyses suggest that birds have the NPAS4L, but not the ETV2, gene in their genomes.
We next asked whether NPAS4L plays a role in early hemangioblast specification in chick as was shown in zebrafish. For this purpose, we generated an RNA wholemount in situ hybridization (WISH) probe for chicken NPAS4L and performed WISH using embryos from stage HH3 (early gastrulation) to stage HH12 (onset of circulation). Expression of chicken NPAS4L was detected in territories marking nascent hemangioblasts in ventral mesoderm (Figure 2A) from stage HH3+, the earliest among all hemangioblast-specific genes (e.g., SCL/TAL1 and LMO2 expression starts from stage HH4+). This observation was confirmed by WISH using left-right bisected embryos, with the left half stained for NPAS4L and the right half stained for SCL/TAL1 and Chordin (Figure 2C). Paraffinsectioning of stained embryos (Figure 2B) showed that NPAS4L-positive cells are located in a subset of the mesoderm germ layer that will give rise to blood and endothelial cell lineages (red arrows; germ layers marked by arrowheads and brackets), as we had previously reported. 10,21 NPAS4L expression levels peaked at HH7 and declined soon afterwards (Figure 2A), suggesting that this gene is specifically and transiently involved in hemangioblast formation, but not in their differentiation.
We have previously generated the chicken promoterome database, spanning the entire 21-day period of embryonic development.22 When we searched this data- base (http://fantom.gsc.riken.jp/zenbu/), NPAS4L was shown (Figure 3A) to be only expressed in a narrow time window with its peak expression at HH7, consistent with the WISH data. To evaluate its molecular function, we used CRISPRa (CRISPR-mediated gene activation; also known as CRISPR-on)23 to ectopically express this gene. CRISPRa utilizes a modified Cas9 protein (with dead nuclease activity and fused with ten copies of VP16 transactivation domain) to recruit transcriptional machinery to targeted promoters mediated by single guide RNA (sgRNA). We had previously confirmed the effectiveness of CRISPRa system in the avian model by taking advantage of the single-nucleotide level resolution in transcription start site (TSS) mapping.22 Four sgRNA sequences located within the 500-base pair region preceding the NPAS4L TSS were selected (Figure 3) (for interactive view of NPAS4L TSS, use the link http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=b1zZI1gUFZ6mHX6-4Gvxr;loc=galGal5::chr3:4300587..4304021+) and cloned into expression construct pAC154-dual-dCas9VP160- sgExpression (Addgene #48240). Mesoderm precursors in the streak in HH2/3 embryos were targeted for electroporation (see Weng and Sheng19 for electroporation protocol) with these four sgRNA expression constructs together with marker GFP expression construct (Figure 3C), and electroporated embryos were assessed for ectopic expression of endogenous NPAS4L and of two hemangioblast markers SCL/TAL1 and LMO2. NPAS4L CRISPRa constructs were able to ectopically activate endogenous NPAS4L (Figure 3D, oval areas) (11 of 12; 92%) in regions that are normally NPAS4L-negative (Figure 2A), as well as hemangioblast markers SCL/TAL1 (9 of 25; 36%) and LMO2 (6 of 21; 29%) (Figure 3E, oval areas in left two panels), albeit with reduced efficiency. Interestingly, similar inductive effect (5 of 13 for LMO2 and 4 of 9 for SCL/TAL1) was observed when we used zebrafish NPAS4L expression construct4 (cloned into the pCAGGS expression vector) (Figure 3E, oval area in right panel), supporting partial molecular conservation between the zebrafish and chicken NPAS4L genes.
In conclusion, we present evidence that during early chicken development, NPAS4L, instead of ETV2, is involved in hemangioblast formation. Data from our molecular phylogenetic analyses support the hypothesis that both the NPAS4L and ETV2 genes were present in the common reptilian ancestor and likely also in the common amniote ancestor (Figure 3F). A conclusive confirmation of their epistatic relationship, however, requires additional evidence from gain-of-function of ETV2 (e.g., using a reptilian ETV2 ortholog) and loss-of-function of NPAS4L (e.g., through CRISPR-mediated transcription inhibition) studies. In birds and other reptilian lineages which lack the ETV2 ortholog in their genome, it is possible that other ETS family genes have been co-opted to play hemangioblast-specific roles of ETV2. Because ETV2 and NPAS4L are transcription factors with different DNA binding specificities and co-factor requirements, it remains to be shown how ETV2 took over molecular functions of NPAS4L during early mammalian evolution.
- Porcher C, Chagraoui H, Kristiansen MS. SCL/TAL1: a multifaceted regulator from blood development to disease. Blood. 2017; 129(15):2051-2060. https://doi.org/10.1182/blood-2016-12-754051PubMedGoogle Scholar
- Morishima T, Krahl AC, Nasri M. LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis. Blood. 2019; 134(14):1159-1175. https://doi.org/10.1182/blood.2019000095PubMedPubMed CentralGoogle Scholar
- Kataoka H, Hayashi M, Nakagawa R. Etv2/ER71 induces vascular mesoderm from Flk1+PDGFRalpha+ primitive mesoderm. Blood. 2011; 118(26):6975-6986. https://doi.org/10.1182/blood-2011-05-352658PubMedGoogle Scholar
- Reischauer S, Stone OA, Villasenor A. Cloche is a bHLH-PAS transcription factor that drives haemato-vascular specification. Nature. 2016; 535(7611):294-298. https://doi.org/10.1038/nature18614Google Scholar
- Liao EC, Paw BH, Oates AC, Pratt SJ, Postlethwait JH, Zon LI. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev. 1998; 12(5):621-626. https://doi.org/10.1101/gad.12.5.621PubMedPubMed CentralGoogle Scholar
- Marass M, Beisaw A, Gerri C. Genome-wide strategies reveal target genes of Npas4l associated with vascular development in zebrafish. Development. 2019; 146(11)https://doi.org/10.1242/dev.173427PubMedGoogle Scholar
- Nagai H, Shin M, Weng W. Early hematopoietic and vascular development in the chick. Int J Dev Biol. 2018; 62(1-2-3):137-144. https://doi.org/10.1387/ijdb.170291gsPubMedGoogle Scholar
- Zon LI. Developmental biology of hematopoiesis. Blood. 1995; 86(8):2876-2891. https://doi.org/10.1182/blood.V86.8.2876.2876PubMedGoogle Scholar
- Shivdasani RA, Orkin SH. The transcriptional control of hematopoiesis. Blood. 1996; 87(10):4025-4039. https://doi.org/10.1182/blood.V87.10.4025.bloodjournal87104025PubMedGoogle Scholar
- Nakazawa F, Nagai H, Shin M, Sheng G. Negative regulation of primitive hematopoiesis by the FGF signaling pathway. Blood. 2006; 108(10):3335-3343. https://doi.org/10.1182/blood-2006-05-021386PubMedGoogle Scholar
- Shin M, Nagai H, Sheng G. Notch mediates Wnt and BMP signals in the early separation of smooth muscle progenitors and blood/endothelial common progenitors. Development. 2009; 136(4):595-603. https://doi.org/10.1242/dev.026906PubMedGoogle Scholar
- Minko K, Bollerot K, Drevon C, Hallais MF, Jaffredo T. From mesoderm to blood islands: patterns of key molecules during yolk sac erythropoiesis. Gene Expr Patterns. 2003; 3(3):261-272. https://doi.org/10.1016/S1567-133X(03)00053-XGoogle Scholar
- Davidson AJ, Zon LI. The 'definitive' (and 'primitive') guide to zebrafish hematopoiesis. Oncogene. 2004; 23(43):7233-7246. https://doi.org/10.1038/sj.onc.1207943PubMedGoogle Scholar
- Walmsley M, Cleaver D, Patient R. Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development. Blood. 2008; 111(3):1157-1166. https://doi.org/10.1182/blood-2007-03-081323PubMedGoogle Scholar
- Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008; 132(4):631-644. https://doi.org/10.1016/j.cell.2008.01.025PubMedPubMed CentralGoogle Scholar
- Manaia A, Lemarchandel V, Klaine M. Lmo2 and GATA-3 associated expression in intraembryonic hemogenic sites. Development. 2000; 127(3):643-653. Google Scholar
- Drake CJ, Fleming PA. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood. 2000; 95(5):1671-1679. Google Scholar
- Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. J Morphol. 1951; 88(1):49-92. https://doi.org/10.1002/jmor.1050880104PubMedGoogle Scholar
- Weng W, Sheng G. Five transcription factors and FGF pathway inhibition efficiently induce erythroid differentiation in the epiblast. Stem Cell Reports. 2014; 2(3):262-270. https://doi.org/10.1016/j.stemcr.2014.01.019PubMedPubMed CentralGoogle Scholar
- Liu F, Li D, Yu YY. Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2. EMBO Rep. 2015; 16(5):654-669. https://doi.org/10.15252/embr.201439939PubMedPubMed CentralGoogle Scholar
- Weng W, Sukowati EW, Sheng G. On hemangioblasts in chicken. PLoS One. 2007; 2(11):e1228. https://doi.org/10.1371/journal.pone.0001228PubMedPubMed CentralGoogle Scholar
- Lizio M, Deviatiiarov R, Nagai H. Systematic analysis of transcription start sites in avian development. PLoS Biol. 2017; 15(9):e2002887. https://doi.org/10.1371/journal.pbio.2002887PubMedPubMed CentralGoogle Scholar
- Cheng AW, Wang H, Yang H. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 2013; 23(10):1163-1171. https://doi.org/10.1038/cr.2013.122PubMedPubMed CentralGoogle Scholar
Figures & Tables
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.